AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10219067 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 34
Study 7776987 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 ml of lactose-hydrolyzed milk containing 2 percent fat
Number of subjects: 30
Study 7776987 — intervention group
Group type: COMPARATOR
Intervention: 240 ml of milk containing 2 percent fat and sweetened with aspartame
Number of subjects: 30
Study 7776987 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose-malabsorption group
Number of subjects: 30
Study 2137976 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafarelin, 200 micrograms twice daily
Number of subjects: 194
Study 2137976 — intervention group
Group type: COMPARATOR
Intervention: Danazol, 200 mg twice daily
Number of subjects: 194
Study 7401172 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based smoking prevention program
Number of subjects: 1526
Study 7401172 — intervention group
Group type: EXPERIMENTAL
Intervention: Curriculum elements emphasizing immediate social consequences of smoking
Number of subjects: 1526
Study 7401172 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalization of course materials with peer role models and active role playing
Number of subjects: 1526
Study 7401172 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiocyanate analysis of saliva samples
Number of subjects: 1526
Study 30940558 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate delivery
Number of subjects: 704
Study 30940558 — intervention group
Group type: COMPARATOR
Intervention: Expectant monitoring
Number of subjects: 704
Study 28807395 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual embryo transfers (iETs) in the experimental group
Number of subjects: 499
Study 28807395 — intervention group
Group type: COMPARATOR
Intervention: Frozen-thawed embryo transfers in the control group
Number of subjects: 499
Study 28807395 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinopode scoring >85
Number of subjects: 499
Study 28807395 — intervention group
Group type: COMPARATOR
Intervention: Pinopode scoring ≤85
Number of subjects: 499
Study 25863797 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily maximum respiratory rate (maxRR)
Number of subjects: 120
Study 25863797 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily median respiratory rate (medRR)
Number of subjects: 120
Study 25863797 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily minimum respiratory rate (minRR)
Number of subjects: 120
Study 25863797 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard deviation of median respiratory rate (medRR)
Number of subjects: 120
Study 23261207 — intervention group
Group type: EXPERIMENTAL
Intervention: PHAROS Vitesse neurovascular balloon-expandable stent system plus medical therapy
Number of subjects: 112
Study 23261207 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 112
Study 20868456 — intervention group
Group type: COMPARATOR
Intervention: Southern regular implants and standard ball attachments (control)
Number of subjects: 36
Study 20868456 — intervention group
Group type: EXPERIMENTAL
Intervention: Southern 8-mm-wide implants and large ball attachments
Number of subjects: 36
Study 20868456 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoss regular implants and Locator attachments
Number of subjects: 36
Study 20868456 — intervention group
Group type: EXPERIMENTAL
Intervention: Southern 8-mm-wide implants and large ball attachments and Neoss regular implants and Locator attachments
Number of subjects: 36
Study 19615989 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-quantitative procalcitonin measurement (PCT-Q)
Number of subjects: 359
Study 19615989 — intervention group
Group type: COMPARATOR
Intervention: Quantitative procalcitonin measurement (Kryptor)
Number of subjects: 359
Study 16705849 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus SASP and MTX
Number of subjects: 90
Study 16705849 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite sulfur (tablet) moxibustion plus SASP and MTX
Number of subjects: 90
Study 16705849 — intervention group
Group type: COMPARATOR
Intervention: SASP and MTX
Number of subjects: 90
Study 15568609 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 11281583 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/ml MMC applied for 5 minutes
Number of subjects: 46
Study 11281583 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/ml MMC applied for 5 minutes
Number of subjects: 46
Study 11281583 — intervention group
Group type: COMPARATOR
Intervention: Standard EXT-DCR procedure (Control group)
Number of subjects: 46
Study 9207749 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG 0.1 mg + 6 x 10(8) KML
Number of subjects: 997
Study 9207749 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG 0.1 mg + 5 x 10(7) KML
Number of subjects: 997
Study 9207749 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG 0.1 mg + 5 x 10(6) KML
Number of subjects: 997
Study 9207749 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG 0.05 mg + 6 x 10(8) KML
Number of subjects: 997
Study 9207749 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG 0.05 mg + 5 x 10(7) KML
Number of subjects: 997
Study 9207749 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG 0.01 mg + 5 x 10(7) KML
Number of subjects: 997
Study 9207749 — intervention group
Group type: COMPARATOR
Intervention: BCG 0.1 mg
Number of subjects: 997
Study 8491164 — intervention group
Group type: EXPERIMENTAL
Intervention: Test snack with uncooked cornstarch (complex carbohydrates)
Number of subjects: 9
Study 8491164 — intervention group
Group type: COMPARATOR
Intervention: Standard evening snack (control)
Number of subjects: 9
Study 2908765 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidamidine (20 mg p.o.)
Number of subjects: 27
Study 2908765 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (0.3 mg p.o.)
Number of subjects: 27
Study 2908765 — intervention group
Group type: EXPERIMENTAL
Intervention: Idazoxan (20 mg p.o.)
Number of subjects: 27
Study 2908765 — intervention group
Group type: COMPARATOR
Intervention: Basal conditions (Control)
Number of subjects: 27
Study 30146435 — intervention group
Group type: EXPERIMENTAL
Intervention: Team-based learning (TBL)
Number of subjects: 112
Study 30146435 — intervention group
Group type: COMPARATOR
Intervention: Lecture
Number of subjects: 112
Study 27399998 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenazopyridine
Number of subjects: 104
Study 27399998 — intervention group
Group type: COMPARATOR
Intervention: No medications (Control)
Number of subjects: 104
Study 25197734 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% triphala mouthrinse
Number of subjects: 120
Study 25197734 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine mouthrinse
Number of subjects: 120
Study 25197734 — intervention group
Group type: COMPARATOR
Intervention: Negative control
Number of subjects: 120
Study 22808713 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-minute rest between sets
Number of subjects: 20
Study 22808713 — intervention group
Group type: COMPARATOR
Intervention: 1-minute rest between sets
Number of subjects: 20
Study 22808713 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta CK activity
Number of subjects: 20
Study 22808713 — intervention group
Group type: EXPERIMENTAL
Intervention: Total volume of exercise completed
Number of subjects: 20
Study 20829244 — intervention group
Group type: EXPERIMENTAL
Intervention: Sativex (nabiximols)
Number of subjects: 135
Study 20829244 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 19122958 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy (liquid nitrogen)
Number of subjects: 60
Study 19122958 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 percent phenol solution
Number of subjects: 60
Study 17313876 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise rehabilitation (3-month training period)
Number of subjects: 64
Study 17313876 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise rehabilitation)
Number of subjects: 64
Study 12831585 — intervention group
Group type: EXPERIMENTAL
Intervention: Coasting for 2 days
Number of subjects: 50
Study 12831585 — intervention group
Group type: EXPERIMENTAL
Intervention: Coasting for 3 days
Number of subjects: 50
Study 11742702 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel plus cisplatin (DC)
Number of subjects: 317
Study 11742702 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel plus gemcitabine (DG)
Number of subjects: 317
Study 9431279 — intervention group
Group type: EXPERIMENTAL
Intervention: Education program on HIV/AIDS
Number of subjects: 1063
Study 9431279 — intervention group
Group type: COMPARATOR
Intervention: Control group (comparison condition)
Number of subjects: 1063
Study 8214494 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial regional analgesia with lignocaine 0.5%, 1.5 mg.kg‐1
Number of subjects: 26
Study 8214494 — intervention group
Group type: COMPARATOR
Intervention: Intravenous regional analgesia with lignocaine 0.5%, 3.0 mg.kg‐1
Number of subjects: 26
Study 3440240 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical orchidectomy and chemotherapy for Group I patients
Number of subjects: 95
Study 3440240 — intervention group
Group type: EXPERIMENTAL
Intervention: Orchidectomy, chemotherapy, and radiation therapy for Group II patients
Number of subjects: 95
Study 3440240 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for patients with distant metastases at diagnosis
Number of subjects: 95
Study 3440240 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment for all 95 children
Number of subjects: 95
Study 3440240 — intervention group
Group type: COMPARATOR
Intervention: Comparison to entire IRS series
Number of subjects: 95
Study 30032997 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing home staff (nurses and social workers)
Number of subjects: 302
Study 30032997 — intervention group
Group type: COMPARATOR
Intervention: Nursing home clinicians (physicians and other advanced practitioners)
Number of subjects: 302
Study 28407163 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% nepafenac
Number of subjects: 88
Study 28407163 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03% flurbiprofen
Number of subjects: 88
Study 28407163 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% ketorolac
Number of subjects: 88
Study 28407163 — intervention group
Group type: COMPARATOR
Intervention: Lubricant (control group)
Number of subjects: 88
Study 25622243 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (1.2 g administered 1 hour before the second tlim trial)
Number of subjects: 20
Study 25622243 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose administered 1 hour before the second tlim trial)
Number of subjects: 20
Study 23946263 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 0
Study 23946263 — intervention group
Group type: COMPARATOR
Intervention: Best medical therapy
Number of subjects: 0
Study 21775979 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (14 days treatment)
Number of subjects: 0
Study 21775979 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study 18313592 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline SF-36 physical summary scores
Number of subjects: 740
Study 18313592 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline QoL Index summary scores
Number of subjects: 740
Study 18313592 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline Patient Concerns Checklist summary scores
Number of subjects: 740
Study 18313592 — intervention group
Group type: EXPERIMENTAL
Intervention: QoL measures examined simultaneously
Number of subjects: 740
Study 16540949 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary trypsin inhibitor (5000 units/kg intravenous)
Number of subjects: 30
Study 16540949 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 30
Study 12656696 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole-based triple therapy
Number of subjects: 0
Study 12656696 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole plus placebos
Number of subjects: 0
Study 10720525 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime (n=34)
Number of subjects: 68
Study 10720525 — intervention group
Group type: COMPARATOR
Intervention: Imipenem (n=34)
Number of subjects: 68
Study 10720525 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Ceftazidime and Imipenem)
Number of subjects: 68
Study 7490894 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered alfentanil via a patient controlled infusion pump
Number of subjects: 44
Study 7490894 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving alfentanil infusion titrated by anesthesiologists
Number of subjects: 44
Study 29186989 — intervention group
Group type: EXPERIMENTAL
Intervention: EPVL plus 0.4 mg oral tamsulosin daily (n=236)
Number of subjects: 672
Study 29186989 — intervention group
Group type: COMPARATOR
Intervention: EPVL only (n=214)
Number of subjects: 672
Study 29186989 — intervention group
Group type: COMPARATOR
Intervention: 0.4 mg tamsulosin PO qd (n=222)
Number of subjects: 672
Study 29186989 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (EPVL plus tamsulosin, EPVL only, tamsulosin only)
Number of subjects: 672
Study 29186989 — intervention group
Group type: EXPERIMENTAL
Intervention: EPVL plus tamsulosin
Number of subjects: 672
Study 28730988 — intervention group
Group type: EXPERIMENTAL
Intervention: Keeled all‐polyethylene glenoid component
Number of subjects: 16
Study 28730988 — intervention group
Group type: COMPARATOR
Intervention: Pegged all‐polyethylene glenoid component
Number of subjects: 16
Study 26227188 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine invasive strategy (coronary arteriography and myocardial revascularization as clinically indicated)
Number of subjects: 1810
Study 26227188 — intervention group
Group type: COMPARATOR
Intervention: Selective invasive strategy (coronary arteriography for recurrent ischemia only)
Number of subjects: 1810
Study 26227188 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine invasive strategy
Number of subjects: 1810
Study 26227188 — intervention group
Group type: COMPARATOR
Intervention: Selective invasive strategy
Number of subjects: 1810
Study 26227188 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine invasive strategy and Selective invasive strategy
Number of subjects: 1810
Study 24284002 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC)
Number of subjects: 258
Study 24284002 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined KMC and 24% oral sucrose
Number of subjects: 258
Study 24284002 — intervention group
Group type: COMPARATOR
Intervention: 24% oral sucrose alone
Number of subjects: 258
Study 24284002 — intervention group
Group type: EXPERIMENTAL
Intervention: KMC
Number of subjects: 258
Study 21827441 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mcg/kg dexmedetomidine in 100 ml of normal saline over 10 min; 1 mcg/kg/h dexmedetomidine infusion during surgery
Number of subjects: 40
Study 21827441 — intervention group
Group type: COMPARATOR
Intervention: 100 ml of normal saline over 10 min; 1 ml/kg/h normal saline infusion during surgery
Number of subjects: 40
Study 17873492 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan (8-125 mg b.i.d.)
Number of subjects: 94
Study 17873492 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 15756179 — intervention group
Group type: EXPERIMENTAL
Intervention: ST graft (semitendinosus tendon)
Number of subjects: 97
Study 15756179 — intervention group
Group type: COMPARATOR
Intervention: STG graft (semitendinosus and gracilis)
Number of subjects: 97
Study 12424933 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone (75 mg/kg/day in 12 hourly divided doses)
Number of subjects: 45
Study 12424933 — intervention group
Group type: COMPARATOR
Intervention: Standard quinine and doxycycline therapy with placebo
Number of subjects: 45
Study 10360098 — intervention group
Group type: EXPERIMENTAL
Intervention: Royal College of General Practitioners' mobility screening questionnaire
Number of subjects: 627
Study 8955576 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal corticosteroid treatment
Number of subjects: 27
Study 8955576 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 27
Study 1834440 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus dose of ANF 100 micrograms
Number of subjects: 27
Study 1834440 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of ANF 50 micrograms at 1.67 micrograms/min for 30 min
Number of subjects: 27
Study 1834440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 7070987 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol administration
Number of subjects: 0
Study 7070987 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin administration
Number of subjects: 0
Study 31775999 — intervention group
Group type: EXPERIMENTAL
Intervention: CFR‐PEEK
Number of subjects: 76
Study 31775999 — intervention group
Group type: COMPARATOR
Intervention: Titanium
Number of subjects: 76
Study 28003178 — intervention group
Group type: EXPERIMENTAL
Intervention: Families for Health (FFH)
Number of subjects: 115
Study 28003178 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 115
Study 26096582 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted intervention with Paro (30 minutes twice a week for 12 weeks)
Number of subjects: 60
Study 26096582 — intervention group
Group type: COMPARATOR
Intervention: Control group with treatment as usual
Number of subjects: 60
Study 24924267 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid spray (two pumps, three times daily for 7 days)
Number of subjects: 34
Study 24924267 — intervention group
Group type: COMPARATOR
Intervention: Benzydamine hydrochloride spray (two pumps, three times daily for 7 days)
Number of subjects: 34
Study 22876063 — intervention group
Group type: EXPERIMENTAL
Intervention: CRAB bacteremia patients
Number of subjects: 106
Study 19317300 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged heparin infusion
Number of subjects: 200
Study 19317300 — intervention group
Group type: COMPARATOR
Intervention: No post-procedural heparin (control group)
Number of subjects: 200
Study 17503991 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (mean endpoint dose = 460 ± 88 mg/day)
Number of subjects: 20
Study 17503991 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 20
Study 16036037 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 2
Study 11605083 — intervention group
Group type: EXPERIMENTAL
Intervention: WS1490 (kava-kava special extract)
Number of subjects: 40
Study 11605083 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 9040574 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated hypertensive (n = 207)
Number of subjects: 1651
Study 9040574 — intervention group
Group type: EXPERIMENTAL
Intervention: Untreated hypertensive (n = 402)
Number of subjects: 1651
Study 9040574 — intervention group
Group type: COMPARATOR
Intervention: Normotensive (n = 1042)
Number of subjects: 1651
Study 9040574 — intervention group
Group type: EXPERIMENTAL
Intervention: Home and 24 h blood pressures (treated and untreated hypertensives)
Number of subjects: 1651
Study 9040574 — intervention group
Group type: EXPERIMENTAL
Intervention: Day and night average blood pressures (treated and untreated hypertensives)
Number of subjects: 1651
Study 9040574 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall hypertensive population
Number of subjects: 1651
Study 7701806 — intervention group
Group type: EXPERIMENTAL
Intervention: BC1 (buffy coat platelet concentrates filtered prior to storage)
Number of subjects: 86
Study 7701806 — intervention group
Group type: EXPERIMENTAL
Intervention: BC3 (buffy coat platelet concentrates filtered after 3-4 days' storage)
Number of subjects: 86
Study 7701806 — intervention group
Group type: COMPARATOR
Intervention: Standard platelet-rich plasma (PRP) PCs
Number of subjects: 86
Study 7701806 — intervention group
Group type: COMPARATOR
Intervention: Leukocyte-depleted PRP PCs
Number of subjects: 86
Study 7701806 — intervention group
Group type: EXPERIMENTAL
Intervention: BC1 PCs
Number of subjects: 86
Study 7701806 — intervention group
Group type: EXPERIMENTAL
Intervention: BC3 PCs
Number of subjects: 86
Study 2980999 — intervention group
Group type: EXPERIMENTAL
Intervention: Zimelidine
Number of subjects: 0
Study 2980999 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 0
Study 2980999 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 28388850 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 72
Study 28388850 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 31393279 — intervention group
Group type: EXPERIMENTAL
Intervention: Ground-based walking training (GBWT)
Number of subjects: 95
Study 29187230 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized music
Number of subjects: 60
Study 29187230 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-personalized relaxing music
Number of subjects: 60
Study 29187230 — intervention group
Group type: COMPARATOR
Intervention: Attention-control
Number of subjects: 60
Study 25342388 — intervention group
Group type: EXPERIMENTAL
Intervention: One-year aerobic and strength exercise intervention (150 min/week)
Number of subjects: 189
Study 25342388 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 189
Study 23512956 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 kcal/day
Number of subjects: 125
Study 23512956 — intervention group
Group type: COMPARATOR
Intervention: 1,500 kcal/day
Number of subjects: 125
Study 21502288 — intervention group
Group type: EXPERIMENTAL
Intervention: Lengthening MVCs
Number of subjects: 12
Study 21502288 — intervention group
Group type: COMPARATOR
Intervention: Isometric MVCs
Number of subjects: 12
Study 18970943 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonrigid fixation using sutures
Number of subjects: 16
Study 18970943 — intervention group
Group type: COMPARATOR
Intervention: Rigid fixation using titanium or resorbable osteosynthesis plates
Number of subjects: 16
Study 16946074 — intervention group
Group type: EXPERIMENTAL
Intervention: Social-psychological intervention (brief in-class writing assignment)
Number of subjects: 0